Medpharm

Overview

MedPharm is a contract development and manufacturing organization (CDMO) specializing in topical, transdermal, and transepithelial drug products. Founded in 1999 within the scientific community at King's College London, the company has grown into a global CDMO with facilities in Guildford, UK, and Durham, North Carolina, USA.

Core Services

MedPharm provides integrated support across the full product lifecycle:

• Formulation Development: Strategic formulation development for topical and transepithelial drug products, optimizing delivery, stability, and patient performance.
• Analytical & Testing Services: Comprehensive analytical and testing services including raw material testing, stability testing, in vitro release testing (IVRT), in vitro permeation testing (IVPT), bioanalytical services, and Olink® proteomic analysis.
• Process Development & Scale-Up: Process development and scale-up to translate formulations from lab to manufacturing, ensuring robust, reproducible performance at commercial scale.
• Clinical Trial Material (CTM) Supply: Clinical trial material manufacturing and supply supporting early- and late-stage studies.
• Commercial Manufacturing: Scalable GMP manufacturing for semi-solid and liquid drug products, supporting clinical supply through commercial production.
• Packaging and Serialization: Services supporting final drug product preparation.
• Research Biology: In vitro models and research biology services to evaluate drug release, permeation, and pharmacological activity.

Routes of Delivery

MedPharm has specialized expertise across multiple delivery routes including skin, nail, eye, respiratory (nasal and lung), mucosal, and specialized/unconventional delivery systems.

Regulatory & Quality

Development and manufacturing aligned with expectations from global health authorities including the FDA, EMA, and MHRA. The company emphasizes quality assurance and regulatory standards compliance throughout all programs.